Leanne Thalji, Nassir M. Thalji, Julie K. Heimbach, Samar H. Ibrahim, Patrick S. Kamath, Andrew Hanson, Phillip J. Schulte, Dawit T. Haile, Daryl J. Kor – 2 June 2020
Sandra De Jonghe, Daniel Weinstock, Jason Aligo, Kay Washington, Dean Naisbitt – 2 June 2020
Sandra De Jonghe, Daniel Weinstock, Jason Aligo, Kay Washington, Dean Naisbitt – 2 June 2020
Sanjay Kumar Yadav, Narendr Singh Choudhary, Arvinder Singh Soin – 2 June 2020
Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Sezai Yilmaz – 2 June 2020
Douglas Motomura, Tara Baetz, Andrea Grin, Jennifer A. Flemming – 2 June 2020
Xin Wang, Ling‐yue Dong, Qu‐jing Gai, Wei‐lun Ai, Yuan Wu, Wei‐chun Xiao, Jing Zhang, Wei An – 2 June 2020 – It is well known that excessive cholesterol accumulation within hepatocytes deteriorates nonalcoholic fatty liver disease (NAFLD). Augmenter of liver regeneration (ALR) has been reported to alleviate NAFLD through anti‐apoptosis; however, whether ALR could protect liver from cholesterol‐induced NAFLD remains unclear.
Douglas Motomura, Tara Baetz, Andrea Grin, Jennifer A. Flemming – 2 June 2020
Marco Merli, Giovanni Perricone, Andrea Lauterio, Manlio Prosperi, Giovanna Travi, Elena Roselli, Laura Petrò, Luciano De Carlis, Luca Belli, Massimo Puoti – 31 May 2020
Ioannis A. Ziogas, Laura A. Hickman, Lea K. Matsuoka, Manhal Izzy, Martin I. Montenovo, Scott A. Rega, Irene D. Feurer, Sophoclis P. Alexopoulos – 31 May 2020 – Despite the divergent disease biology of cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), wait‐list prioritization is identical for both diagnoses. We compared wait‐list and posttransplant outcomes between CCA and HCC liver transplantation patients with Model for End‐Stage Liver Disease exceptions using Scientific Registry of Transplant Recipients data.